Vertex Pharmaceuticals’ (VRTX) Hold Rating Reaffirmed at Needham & Company LLC
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “hold” rating reaffirmed by investment analysts at Needham & Company LLC in a research note issued on Tuesday,Benzinga reports. Several other analysts have also recently weighed in on the company. Barclays boosted their price target on Vertex Pharmaceuticals from $435.00 to $467.00 and gave the […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “hold” rating reaffirmed by investment analysts at Needham & Company LLC in a research note issued on Tuesday,Benzinga reports. Several other analysts have also recently weighed in on the company. Barclays boosted their price target on Vertex Pharmaceuticals from $435.00 to $467.00 and gave the […]
